For cancer patients, clinical trials are a necessary care option and often the only piece of hope left when standard-of-care treatments fail. Unfortunately, less than five percent of cancer patients currently participate in clinical trials, though more than 70 percent could benefit from an oncology clinical trial. To close this gap, a model that provides more cancer patients the option to participate needs to be created. In this webinar, the featured speakers discuss concerns in clinical research in oncology and in-home clinical trial care.
One solution in ensuring more cancer patients have access and ability to participate in a clinical trial, is to offer in-home visits as part of the clinical trial. Having the option to be cared for at home where possible — in-between or as part of the protocol required visits — decreases the burden of traveling to a site. In addition, it minimizes the stress involved in the logistics of an already burdensome life with frequent visits for complete care. In-home care also helps a patient go home sooner after intensive treatments like CAR T therapy.
Although the benefits of in-home healthcare are undisputed, the logistics and liabilities associated with providing in-home trial support to cancer patients do create new problems that need to be solved. It is important to ensure critical data are collected for the trial in a new way.
Technology is one of the best ways to ensure these data can be collected from the home trial visit. The speakers will discuss technology solutions that will make in-home healthcare more accessible to patients.
Join this webinar to learn how in-home healthcare can become a more viable care option for more cancer patients.
Esther Howard, Oncology Advisor THREAD Research
THREAD Research is a leading provider of decentralized clinical trial (DCT) technologies for life sciences. In her role, Esther oversees THREAD’s oncology strategy and collaborates directly with clients to help them build the best oncology solution in a DCT design that integrates with THREAD’s platform.
Esther is committed to the mission of improving the lives of cancer patients, globally. She has 20 years of experience in the healthcare and clinical research industry, primarily in oncology drug development at PRA Health Sciences (now ICON) and Labcorp Oncology. For the past five years, Esther has been working hard to bring clinical research as a care option for cancer patients and is now working with THREAD and THREAD’s customers to design and innovate to achieve this mission.Message Presenter
Chris Watson, Director, Consulting, THREAD Research
Chris has over 27 years’ experience in product and service development within regulated industries across multiple markets. The last 13+ years have focused on clinical technologies; including tools and platforms to engage, educate and retain participants (and their families) in clinical studies. Chris is a recognized subject matter expert in eCOA and patient engagement, with a proven ability in the technical domain. Chris believes in the utilization of technology for the benefit of all and is a proponent of change, so that our industry can support the globalization of clinical research, which supports diverse participant populations.Message Presenter
Todd McGrath, Senior Vice President, Portfolio Delivery, MRN
Todd has over 18 years’ experience in the clinical trial and life science industry; beginning his career in pharmaceutical and biotech consulting and then holding operational positions at PAREXEL managing teams and projects. Today, Todd oversees MRN’s global operations teams, developing and implementing Project Management strategy, continuous improvement, and standardization across all regions. Todd’s leadership has been instrumental to MRN’s pharma clients, guiding them through operational challenges during and through the pandemic. His passion is making trials more accessible and less burdensome for patients and their families, allowing more people to participate in trials and getting drugs to the market and patients, faster.Message Presenter
Who Should Attend?
- Clinical Research
- Clinical Project Managers
- Data Management
- Decentralized/Remote/Virtual Trials
- Digital Innovation/Strategy
- Medical Director
- Patient Experience
- Patient Engagement
- Patient Recruitment
- Trial Design
- Therapeutic Head/Lead
What You Will Learn
Attendees will learn:
- The logistics of clinical care in the home for patients through Home Trial Support (HTS)
- From an oncology perspective, what problems can be solved to support patients, sites and sponsors?
- The technology that bridges it all together — data collection, how to combine in-home clinical and digital care
THREAD is a leading provider of a proprietary, decentralized research platform and suite of supporting services used by biopharma, CROs and life science organizations to remotely capture data from participants and sites during, in-between and in lieu of in-clinic visits. THREAD’s platform and supporting services are helping customers to shorten study launch timelines, reduce study budgets with Virtual Visits, and bring studies from the clinic to patients’ homes. THREAD provides key platform features such as eConsent, eCOA/ePRO, sensors, reminders, and telehealth Virtual Visits to support remote data capture, hybrid virtual studies, and fully decentralized studies in key therapeutic areas. In 2019, THREAD was acquired by strategic health care investors Water Street Healthcare Partners and JLL Partners. Visit us at https://www.threadresearch.com/
MRN has led the way efficiently delivering high quality complex Decentralized Clinical Trials (DCT) from patients’ homes for over 16 years. We understand the complexities of today’s clinical trial environment and the burden placed on both patients and sites. Our decentralized trial and site support solutions are designed to ease these burdens, therefore accelerating patient recruitment, enrollment, and retention, maximizing the impact of the trial for the pharmaceutical sponsor – getting drugs to market faster. MRN are the catalysts of decentralized trials; combining the right clinical and digital DCT elements, to engineer the right solution for each trial.